Reverse stock split

Which biotech action will shock the market in 2022?

In 2019, tiny Axsome Therapeutics (NASDAQ: AXSM) emerged from the obscurity of micro-caps to become the best performing stock in the market, increasing an incredible 3,600% in one year. In 2020, another small biotech, Novavax (NASDAQ: NVAX), came out of nowhere to trample the stock market, its share price skyrocketing …

Read More »

1-For-6 Reverse Split takes effect

Catabasis Pharmaceuticals Inc (NASDAQ: CATB) has rolled out a reverse stock consolidation of its common stock at a ratio of 1 to 6. These are the details. Catabasis Pharmaceuticals Inc (NASDAQ: CATB) has rolled out a common stock split of its common stock at a ratio of 1 to 6, …

Read More »